Do head and neck cancer patients benefit from treatment in certified centres? Specific results of the WiZen study for head and neck cancers
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S341
DOI: 10.1055/s-0044-1785159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Max Kemper und 16 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
In Germany, around 16,000 new patients are diagnosed with a head and neck cancer (HNC) every year. The individual treatment concepts should be determined on an interdisciplinary basis and carried out according to current guidelines. To ensure this, the national cancer plan was implemented in 2008. Since then, 76 head and neck tumour centres (HNCC) (78 locations) have been certified by the German Hospital Association (DKG). Certification is very challenging, both financially and in terms of personnel. The question therefore arises as to whether HNC patients really benefit from treatment in certified HNCC.
Methods
In the WiZen study, patient-specific data from statutory health insurance (GKV) of AOK and clinical cancer registries (CCR) from 2009 to 2017 as well as hospital characteristics from the structured quality reports were analysed. Multivariable Cox regression was used to analyse the differences in the survival of HNC patients who were initially treated in hospitals with and without a certificate.
Results
It was possible to analyse 52,749 HNC patient records from the GKV and 15,287 from the CCR. These were initially treated in 872 hospitals (44 with vs. 828 without a certificate). Accordingly, 15.5% (GKV) and 25.9% (CCR) of patients were treated in certified HNCC. The mortality risk for treatment in a certified HNCC was significantly lower in comparison (SHI data: HR=0.94; CCR data: HR=0.89). The significant difference in recurrence-free survival was even more pronounced (CCR data: HR=0.81).
Conclusion
The WiZen study shows that treatment in a DKG-certified KHT centre is associated with lower mortality. Centralising the care of HNC-patients to certified HNCC therefore seems sensible. Funding information Innovation Fund of the Joint Federal Committee, (Gemeinsamer Bundesausschluss, G-BA), Germany | Funding number 01CSF17020 Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Kemper, M., Schoffer, O., Gerken, M., Bierbaum, V., Bobeth, C., Rößler, M., Dröge, P., Ruhnke, T., Günster, C., Tol, K. K., Reichert, T., Kummer, P., Kölbl, O., Zahnert, T., Keerl, R., Klinkhammer-Schalke, M., & Schmitt, J. (2024). Do head and neck cancer patients benefit from treatment in certified centres? Specific results of the WiZen study for head and neck cancers. Laryngo-Rhino-Otologie, 103(S 02 S 02), S341. https://doi.org/10.1055/s-0044-1785159
Vancouver
Kemper M, Schoffer O, Gerken M, Bierbaum V, Bobeth C, Rößler M, et al. Do head and neck cancer patients benefit from treatment in certified centres? Specific results of the WiZen study for head and neck cancers. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S341. doi:10.1055/s-0044-1785159
BibTeX
@article{Kemper2024,
author = {Kemper, Max and Schoffer, Olaf and Gerken, Michael and Bierbaum, Veronika and Bobeth, Christoph and Rößler, Martin and Dröge, Patrik and Ruhnke, Thomas and Günster, Christian and Tol, Kees Kleihues-van and Reichert, Torsten and Kummer, Peter and Kölbl, Oliver and Zahnert, Thomas and Keerl, Rainer and Klinkhammer-Schalke, Monika and Schmitt, Jochen},
title = {Do head and neck cancer patients benefit from treatment in certified centres? Specific results of the WiZen study for head and neck cancers},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S341},
doi = {10.1055/s-0044-1785159}
}
EUVIMED